Prostate cancer: New light shed on the anticancer effects of zoledronic acid

Nature Reviews Urology

Volumn 9, Issue 5, 2012, Pages 235-

  Clyne, Melanie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA1 INTEGRIN; BETA4 INTEGRIN; CYCLIN E; PHOSPHOTRANSFERASE; PROTEIN P21; PROTEIN P27; ZOLEDRONIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HUMAN; INTRACELLULAR SIGNALING; METASTASIS INHIBITION; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 84862171465     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.70     Document Type: Note

References (1)

1. Mani, J. et al. Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro. Prostate Cancer Prostatic Dis. doi:10.1038/pcan.2012.9